musaddiqalii

musaddiqalii

Last seen: 6 days ago

Member since Mar 21, 2025

Following (0)

Followers (0)

Liam Neeson's NYC apartment with Central Park views finds new owner

Liam Neeson's NYC apartment with Central Park views fin...

Jul 20, 2025  0

Liam Neeson's apartment in New York City has found a new owner after four months...

Best CD rates today, July 20, 2025 (lock in up to 5.5% APY)

Best CD rates today, July 20, 2025 (lock in up to 5.5% ...

Jul 20, 2025  0

Tesla and These 5 Other Stocks Face a Challenging Week of Earnings

Tesla and These 5 Other Stocks Face a Challenging Week ...

Jul 20, 2025  0

What You Need to Know Ahead of Cognizant Technology’s Earnings Release

What You Need to Know Ahead of Cognizant Technology’s E...

Jul 20, 2025  0

What to Expect From CDW’s Next Quarterly Earnings Report

What to Expect From CDW’s Next Quarterly Earnings Report

Jul 20, 2025  0

What to Expect From ANSYS’ Q2 2025 Earnings Report

What to Expect From ANSYS’ Q2 2025 Earnings Report

Jul 20, 2025  0

Earnings Preview: What to Expect From Ingersoll Rand’s Report

Earnings Preview: What to Expect From Ingersoll Rand’s ...

Jul 20, 2025  0

Offerpad Solutions (OPAD) Announces Strategic Partnership with Auction.com

Offerpad Solutions (OPAD) Announces Strategic Partnersh...

Jul 20, 2025  0

Viomi Technology (VIOT) Announces Approval of a Special Dividend

Viomi Technology (VIOT) Announces Approval of a Special...

Jul 20, 2025  0

JP Morgan Maintains a Neutral Stance on ProKidney Corp. (PROK)

JP Morgan Maintains a Neutral Stance on ProKidney Corp....

Jul 20, 2025  0

Above Food Ingredients (ABVE) Announces Acquisition of Palm Global Technologies

Above Food Ingredients (ABVE) Announces Acquisition of ...

Jul 20, 2025  0

H.C. Wainwright Upgrades Vor Biopharma (VOR) to a Buy, Sets a $3 Price Target

H.C. Wainwright Upgrades Vor Biopharma (VOR) to a Buy, ...

Jul 20, 2025  0

H.C. Wainwright Reiterates a Buy Rating on Lexicon Pharmaceuticals (LXRX)

H.C. Wainwright Reiterates a Buy Rating on Lexicon Phar...

Jul 20, 2025  0

BMO Capital Maintains a Buy on Prime Medicine (PRME), Sets a $10 PT

BMO Capital Maintains a Buy on Prime Medicine (PRME), S...

Jul 20, 2025  0

Mizuho Lifts PT on Neumora Therapeutics (NMRA) to $5 from $4, Keeps Outperform Rating

Mizuho Lifts PT on Neumora Therapeutics (NMRA) to $5 fr...

Jul 20, 2025  0

KBW Maintains a Hold on Opendoor Technologies (OPEN)

KBW Maintains a Hold on Opendoor Technologies (OPEN)

Jul 20, 2025  0